DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Picoplatin is an investigational drug.
There have been 8 clinical trials for Picoplatin. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Lung Neoplasms, Colorectal Neoplasms, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are Poniard Pharmaceuticals, National Cancer Institute (NCI), and Jonsson Comprehensive Cancer Center.
Recent Clinical Trials for Picoplatin
|Cardiac Safety Assessment Study of Picoplatin in Solid Tumors||Poniard Pharmaceuticals||Phase 1|
|Study of Picoplatin Efficacy After Relapse||Poniard Pharmaceuticals||Phase 3|
|A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors||Poniard Pharmaceuticals||Phase 1|